| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.099 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |